PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,532,555 | -23.4% | 180,331 | 0.0% | 4.63% | -4.3% |
Q2 2023 | $7,225,863 | -1.8% | 180,331 | 0.0% | 4.84% | -2.1% |
Q1 2023 | $7,359,308 | +5.7% | 180,331 | 0.0% | 4.94% | +5.1% |
Q4 2022 | $6,962,579 | -27.4% | 180,331 | 0.0% | 4.70% | -24.3% |
Q3 2022 | $9,592,000 | -30.1% | 180,331 | -23.4% | 6.21% | -25.3% |
Q2 2022 | $13,726,000 | -28.4% | 235,445 | -6.2% | 8.31% | -5.8% |
Q1 2022 | $19,167,000 | +26.8% | 251,140 | 0.0% | 8.83% | +47.1% |
Q4 2021 | $15,111,000 | +12.4% | 251,140 | +4.6% | 6.00% | +12.5% |
Q3 2021 | $13,448,000 | +3.9% | 240,142 | +12.6% | 5.33% | +8.5% |
Q2 2021 | $12,938,000 | -4.8% | 213,217 | +10.0% | 4.92% | -12.1% |
Q1 2021 | $13,588,000 | +17.1% | 193,860 | 0.0% | 5.59% | +7.3% |
Q4 2020 | $11,601,000 | -0.5% | 193,860 | 0.0% | 5.22% | -27.1% |
Q3 2020 | $11,655,000 | +14.6% | 193,860 | 0.0% | 7.15% | -2.3% |
Q2 2020 | $10,172,000 | +56.5% | 193,860 | 0.0% | 7.32% | +20.7% |
Q1 2020 | $6,500,000 | -26.0% | 193,860 | 0.0% | 6.06% | +23.2% |
Q4 2019 | $8,782,000 | +19.0% | 193,860 | 0.0% | 4.92% | +7.6% |
Q3 2019 | $7,380,000 | +58.0% | 193,860 | +80.5% | 4.58% | +71.6% |
Q2 2019 | $4,671,000 | – | 107,412 | – | 2.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |